Marked reduction in myocardial infarct size due to prolonged infusion of an antioxidant during reperfusion - PubMed (original) (raw)
Marked reduction in myocardial infarct size due to prolonged infusion of an antioxidant during reperfusion
L D Horwitz et al. Circulation. 1994 Apr.
Abstract
Background: There has been controversy about whether early reperfusion of myocardial infarcts causes further necrosis mediated by reactive oxygen species or other mechanisms. Unequivocal evidence that therapeutic agents given only during reperfusion can prevent, rather than delay or modify, injury has been sparse. Failure to account for variables, such as collateral blood flow, that influence infarct size independently and attempts to measure infarct size too early in reperfusion may have limited the sensitivity and specificity of some previous studies.
Methods and results: After 90 minutes of coronary occlusion and 48 hours of reperfusion in a canine model, we examined the effect on infarct size of intravenous infusion of N-(2-mercaptopropionyl)-glycine (MPG), a diffusible antioxidant. Infarct size and region at risk were measured by post-mortem dual perfusion with triphenyl tetrazolium chloride and Evans blue dyes, and regional myocardial blood flow was measured with radioactive microspheres. Infusion of MPG 100 mg.kg-1.h-1, beginning either 15 minutes before the onset of reperfusion or 30 minutes after the onset of reperfusion and continued until 4 hours of reperfusion and followed by an intramuscular dose, reduced infarct size, normalized for both region at risk and the level of collateral blood flow, by 60% and 45%, respectively. When infusion of MPG was limited to the last 15 minutes of ischemia and the first hour of reperfusion only, the normalized infarct size was reduced by 26%. Heart rate, blood pressure, and their product did not differ among the four groups studied. The plasma half-time of MPG was < 10 minutes. In in vitro experiments MPG was a scavenger of hydrogen peroxide but not of superoxide radical.
Conclusions: After 90 minutes of coronary ligation, infusion of the diffusible hydrogen peroxide scavenger, MPG, for several hours, beginning as late as 30 minutes after the onset of reperfusion, substantially reduced infarct size measured 48 hours later. In this model, necrosis caused by processes during reperfusion may be more extensive than necrosis caused by ischemia alone. Since infusion of this agent for only the first hour of reperfusion was considerably less effective, it appears that most of the oxidant injury leading to necrosis occurred after the first 60 minutes but within the first 4 hours of reperfusion.
Similar articles
- Failure of N-2-mercaptopropionyl glycine to reduce myocardial infarction after 3 days of reperfusion in rabbits.
Miki T, Cohen MV, Downey JM. Miki T, et al. Basic Res Cardiol. 1999 Jun;94(3):180-7. doi: 10.1007/s003950050141. Basic Res Cardiol. 1999. PMID: 10424236 - Reduction of canine myocardial infarct size by a diffusible reactive oxygen metabolite scavenger. Efficacy of dimethylthiourea given at the onset of reperfusion.
Carrea FP, Lesnefsky EJ, Repine JE, Shikes RH, Horwitz LD. Carrea FP, et al. Circ Res. 1991 Jun;68(6):1652-9. doi: 10.1161/01.res.68.6.1652. Circ Res. 1991. PMID: 1709840 - Ischaemic preconditioning is not mediated by oxygen derived free radicals in rats.
Richard V, Tron C, Thuillez C. Richard V, et al. Cardiovasc Res. 1993 Nov;27(11):2016-21. doi: 10.1093/cvr/27.11.2016. Cardiovasc Res. 1993. PMID: 8287412 - Leukocytes, oxygen radicals, and myocardial injury due to ischemia and reperfusion.
Werns SW, Lucchesi BR. Werns SW, et al. Free Radic Biol Med. 1988;4(1):31-7. doi: 10.1016/0891-5849(88)90008-1. Free Radic Biol Med. 1988. PMID: 3277898 Review. - Reduction of infarct size by cell-permeable oxygen metabolite scavengers.
Lesnefsky EJ. Lesnefsky EJ. Free Radic Biol Med. 1992;12(5):429-46. doi: 10.1016/0891-5849(92)90092-u. Free Radic Biol Med. 1992. PMID: 1317329 Review.
Cited by
- Cardioprotection by metabolic shut-down and gradual wake-up.
Burwell LS, Nadtochiy SM, Brookes PS. Burwell LS, et al. J Mol Cell Cardiol. 2009 Jun;46(6):804-10. doi: 10.1016/j.yjmcc.2009.02.026. Epub 2009 Mar 10. J Mol Cell Cardiol. 2009. PMID: 19285082 Free PMC article. Review. - Cardioprotection and myocardial reperfusion: pitfalls to clinical application.
Vander Heide RS, Steenbergen C. Vander Heide RS, et al. Circ Res. 2013 Aug 2;113(4):464-77. doi: 10.1161/CIRCRESAHA.113.300765. Circ Res. 2013. PMID: 23908333 Free PMC article. Review. - Controlling Reperfusion Injury With Controlled Reperfusion: Historical Perspectives and New Paradigms.
Fischesser DM, Bo B, Benton RP, Su H, Jahanpanah N, Haworth KJ. Fischesser DM, et al. J Cardiovasc Pharmacol Ther. 2021 Nov;26(6):504-523. doi: 10.1177/10742484211046674. Epub 2021 Sep 17. J Cardiovasc Pharmacol Ther. 2021. PMID: 34534022 Free PMC article. Review. - Mitochondria as a drug target in ischemic heart disease and cardiomyopathy.
Walters AM, Porter GA Jr, Brookes PS. Walters AM, et al. Circ Res. 2012 Oct 12;111(9):1222-36. doi: 10.1161/CIRCRESAHA.112.265660. Circ Res. 2012. PMID: 23065345 Free PMC article. Review. - Timing of adenosine 2A receptor stimulation relative to reperfusion has differential effects on infarct size and cardiac function as assessed in mice by MRI.
Yang Z, Linden J, Berr SS, Kron IL, Beller GA, French BA. Yang Z, et al. Am J Physiol Heart Circ Physiol. 2008 Dec;295(6):H2328-35. doi: 10.1152/ajpheart.00091.2008. Epub 2008 Oct 10. Am J Physiol Heart Circ Physiol. 2008. PMID: 18849340 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical